BSEM BioStem Technologies, Inc. - Common Stock
$3.12
Price · Aug 18, 2026
Fundamentals as of Aug 12, 2026
52W Range
$2–$5
36% of range
Analyst Rating
BUY
7 analysts
Price Target
$7
+124% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
BSEM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.12
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$2 – $5
BSEM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BSEM
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BSEM
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BSEM
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BSEM
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BSEM
Peer Median
BSEM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
1 analysts · 2026-08-18
Low
$7.00
High
$7.00
Median target
$7.00
+124.4%
Mean target
$7.00
+124.4%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.12%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.52 | $-0.51 | -0.01% |
| March 31, 2026 | $-0.52 | $-0.29 | -0.23% |
| Sept. 30, 2025 | $0.03 | $0.00 | 0.03% |
| June 30, 2025 | $-0.03 | $0.33 | -0.36% |
| March 31, 2025 | $-0.01 | $0.02 | -0.03% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BSEM | — | — | — | — | — | — |
| PLRX | $75M | -0.5 | -83.7% | — | -74.4% | — |
| IMA | — | -0.7 | -77.1% | -5668.6% | 192.1% | — |
| TLPH | $56M | — | — | -51035.7% | -120.8% | — |
| SCLX | — | — | — | — | — | — |
| SCYX | $28M | -3.7 | 450.0% | -41.8% | -18.4% | — |
| BTMD | — | 3.5 | -2.5% | 14.1% | -32.9% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 16
| Metric | Trend | Q2 2026 |
|---|---|---|
| Revenue | $8M | |
| Cost of Revenue | $3M | |
| Gross Profit | $5M | |
| R&D Expense | $733.6K | |
| SG&A Expense | $6M | |
| Operating Expenses | $13M | |
| Operating Income | $-8M | |
| Other Non-op | $-594.0K | |
| Pretax Income | $-9M | |
| Income Tax | $0 | |
| Net Income | $-9M | |
| EPS (Basic) | $-0.52 | |
| EPS (Diluted) | $-0.52 | |
| Shares (Basic) | 17,327,652 | |
| Shares (Diluted) | 17,327,652 | |
| EBITDA | $-8M |
Balance Sheet 25
| Metric | Trend | Q2 2026 |
|---|---|---|
| Cash & Equivalents | $7M | |
| Receivables | $7M | |
| Inventory | $5M | |
| Prepaid Expense | $2M | |
| Current Assets | $21M | |
| PP&E (Net) | $4M | |
| PP&E (Gross) | $6M | |
| Accum. Depreciation | $1M | |
| Goodwill | $2M | |
| Intangibles | $21M | |
| Total Assets | $49M | |
| Accounts Payable | $9M | |
| Short-term Debt | $1M | |
| Current Liabilities | $21M | |
| Capital Leases | $1.4K | |
| Total Liabilities | $21M | |
| Long-term Debt | $0 | |
| Total Debt | $1M | |
| Common Stock | $17.8K | |
| Paid-in Capital | $67M | |
| Retained Earnings | $-39M | |
| Treasury Stock | $43.3K | |
| Stockholders' Equity | $28M | |
| Liabilities + Equity | $49M | |
| Shares Outstanding | 17,839,467 |
Cash Flow 2
| Metric | Trend | Q2 2026 |
|---|---|---|
| D&A | $689.3K | |
| Amort. of Intangibles | $653.3K |
Profitability 8
| Metric | Trend | Q2 2026 |
|---|---|---|
| Gross Margin | 61.3% | |
| Operating Margin | -106.3% | |
| Net Margin | -113.6% | |
| Pretax Margin | -113.6% | |
| EBITDA Margin | -106.3% | |
| ROA | -36.8% | |
| ROE | -65.0% | |
| ROIC | -29.4% |
Liquidity & Solvency 3
| Metric | Trend | Q2 2026 |
|---|---|---|
| Current Ratio | 1.0 | |
| Quick Ratio | 0.6 | |
| Debt / Equity | 0.0 |
Efficiency 3
| Metric | Trend | Q2 2026 |
|---|---|---|
| Asset Turnover | 0.3 | |
| Inventory Turnover | 1.3 | |
| Receivables Turnover | 2.4 |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.